Opioid Use Disorder Brain Study Flags 18 Candidate Gene Variants
Postmortem nucleus accumbens tissue from 20 people with opioid use disorder showed 18 candidate variants needing DNA checks and 145 genes more active, led by immune genes.
Read articlePublished research on neuroinflammation.
Postmortem nucleus accumbens tissue from 20 people with opioid use disorder showed 18 candidate variants needing DNA checks and 145 genes more active, led by immune genes.
Read articleIn a 2026 study of 40 male rats under 6 weeks of daily restraint stress, 2 weeks of celecoxib improved open-field, maze and swim-test behavior and lowered hippocampal TNF-alpha, IL-1beta, IL…
Read articleGuanfacine, a non-stimulant ADHD medication, reduced hyperactivity in autistic children in a placebo-controlled trial. A 2026 review argues it may also steady prefrontal brain signaling and …
Read articleA 2026 PLOS One computational study linked Trichostatin A to 949 predicted targets and 8 machine-learning-selected Alzheimer’s disease core genes, but 100 ns molecular dynamics simulations s…
Read articleA 2026 mouse study found that complete IL-6 deficiency worsened motor dysfunction and dopaminergic injury in MPTP and alpha-synuclein A53T Parkinson’s disease models, with earlier and broade…
Read articleA Cell Reports study tied C9orf72-related ALS/FTD inflammation to a gut-bacterial product: inflammatory microbial glycogen appeared in 15 of 22 ALS fecal samples, 1 of 1 C9orf72-frontotempor…
Read articleIn APP/PS1 Alzheimer's model mice, deleting PTP1B or treating with the allosteric inhibitor DPM-1003 improved memory behavior, lowered amyloid burden, and pushed microglia toward SYK-driven …
Read article